The estimated Net Worth of Karen K Mcginnis is at least $2.38 Million dollars as of 18 February 2021. Ms. Mcginnis owns over 666 units of Alphatec Inc stock worth over $8,382 and over the last 23 years she sold ATEC stock worth over $2,295,037. In addition, she makes $78,950 as Independent Director at Alphatec Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ms. McGinnis ATEC stock SEC Form 4 insiders trading
Karen has made over 16 trades of the Alphatec Inc stock since 2002, according to the Form 4 filled with the SEC. Most recently she sold 666 units of ATEC stock worth $324,176 on 18 February 2021.
The largest trade she's ever made was selling 52,625 units of Alphatec Inc stock on 26 February 2002 worth over $1,114,071. On average, Karen trades about 3,995 units every 173 days since 2002. As of 18 February 2021 she still owns at least 1,538 units of Alphatec Inc stock.
You can see the complete history of Ms. Mcginnis stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Karen McGinnis biography
Karen K. McGinnis serves as Independent Director of the Company. Ms. McGinnis has over 20 years of experience in executive operational and finance roles at international public and private companies. She currently serves as the Chief Accounting Officer of Illumina, Inc., a leader in sequencing- and array-based solutions for genetic and genomic analysis. Prior to joining Illumina in November 2017, Ms. McGinnis served from February 2016 to April 2017 as Director, President and Chief Executive Officer of Mad Catz Interactive, Inc. a global provider of innovative interactive entertainment products. From June 2013 through February 2016, Ms. McGinnis served as Mad Catz’ Chief Financial Officer. Prior to joining Mad Catz, Ms. McGinnis served from November 2009 through May 2013 as Chief Accounting Officer of Cymer, Inc., the world’s leading supplier of light sources used in the photolithography process for semiconductor or chip manufacturing until its acquisition in 2013. Ms. McGinnis also served as Chief Accounting Officer for Insight Enterprises, Inc., from September 2006 until March 2009, its Senior Vice President of Finance from 2001 through September 2006 and its Vice President of Finance from 2000 through 2001. She also served as Chief Financial Officer and Treasurer of Horizon from 1997 through 2000 and worked for the assurance practice of KPMG LLP from 1989 through 1997, most recently as a Senior Manager. Ms. McGinnis is a Certified Public Accountant and earned her B.S. Degree in Accounting from the University of Oklahoma.
What is the salary of Karen McGinnis?
As the Independent Director of Alphatec Inc, the total compensation of Karen McGinnis at Alphatec Inc is $78,950. There are 15 executives at Alphatec Inc getting paid more, with Patrick Miles having the highest compensation of $7,960,100.
How old is Karen McGinnis?
Karen McGinnis is 53, she's been the Independent Director of Alphatec Inc since 2019. There are 10 older and 14 younger executives at Alphatec Inc. The oldest executive at Alphatec Holdings Inc is Ward Woods, 77, who is the Independent Director.
What's Karen McGinnis's mailing address?
Karen's mailing address filed with the SEC is C/O ALPHATEC SPINE, INC., 1950 CAMINO VIDA ROBLE, CARLSBAD, CA, 92008.
Insiders trading at Alphatec Inc
Over the last 18 years, insiders at Alphatec Inc have traded over $1,216,108,242 worth of Alphatec Inc stock and bought 24,460,197 units worth $141,338,962 . The most active insiders traders include Mortimer Iii Berkowitz, John Foster, and Llc Hgp. On average, Alphatec Inc executives and independent directors trade stock every 24 days with the average trade being worth of $1,610,824. The most recent stock trade was executed by Evan Bakst on 23 August 2024, trading 35,000 units of ATEC stock currently worth $201,600.
What does Alphatec Inc do?
as a medical technology company, we improve lives by providing innovative spine surgery solutions through our relentless pursuit of superior outcomes. we are dedicated to the design, development, launch and the delivery of spinal fusion products. we seek to accomplish this by working with spine surgeons to design and develop products and systems that address the entire spinal fusion procedure in the most effective and efficient way possible. our product designs and platforms provide innovation through a focus on simplifying procedures for the surgeon with the ultimate objective of superior outcomes. alphatec spine is seeking growth through innovation and continually developing technologies that will have a greater positive impact on patient care and outcomes. please visit our website for more information: www.alphatecspine.com
What does Alphatec Inc's logo look like?
Complete history of Ms. Mcginnis stock trades at Alphatec Inc, Illumina Inc, Insight Enterprises, and Sonendo
Alphatec Inc executives and stock owners
Alphatec Inc executives and other stock owners filed with the SEC include:
-
Patrick Miles,
Chairman of the Board, President, Chief Executive Officer -
David Sponsel,
Executive Vice President - Sales -
Jeffrey Black,
Chief Financial Officer, Executive Vice President -
Patrick S. Miles,
Exec. Chairman, CEO & Pres -
Craig Hunsaker,
Executive Vice President - People & Culture, General Counsel -
David P. Sponsel,
Exec. VP of Sales -
Craig E. Hunsaker,
Exec. VP of People & Culture, Corp. Sec. and Gen. Counsel -
Donald Williams,
Independent Director -
Ward Woods,
Independent Director -
Quentin Blackford,
Independent Director -
David Mowry,
Independent Director -
Jeffrey Rydin,
Director -
James Tullis,
Independent Director -
Jason Hochberg,
Independent Director -
Evan Bakst,
Independent Director -
Karen McGinnis,
Independent Director -
Josh Berg,
IR Contact Officer -
David Pelizzon,
Director -
Mortimer Berkowitz,
Lead Independent Director -
Mark Ojeda,
Executive Vice President - Cervical & Biologics -
Kelli Howell,
Executive Vice President - Clinical Strategies -
Eric Dasso,
Executive Vice President - Adjunctive Technologies -
Brian Snider,
Executive Vice President - Marketing and Development -
Mark D. Ojeda,
Exec. VP of Cervical & Biologics -
Kelli Mari Howell,
Exec. VP of Clinical Strategies -
Dr. Luiz Pimenta,
Chief Medical Officer -
Jonathan Allen,
Exec. VP of Commercial Operations -
Brian R. Snider,
Exec. VP of Marketing -
Scott Lish,
Sr. VP of R&D -
J. Todd Koning,
Chief Financial Officer -
Terry M. Rich,
President & COO -
Leslie H Cross,
Director -
Dennis Nelson,
VP, Finance and Controller -
Stephen Oneil,
Director -
Siri S Marshall,
Director -
R Ian Molson,
Director -
James Corbett,
President and CEO -
Jonathan Allen,
EVP, Commerical Operations -
Michael Joseph Plunkett,
Chief Operating Officer -
Michael O'neill,
CFO and Vice President -
John Foster,
Director -
Ebun Garner,
VP, Legal Affairs & Compliance -
Jennifer N. Pritzker,
10% owner -
David M Demski,
-
Keith Valentine,
-
Healthcare Partners, Llc Se...,
-
Mitsuo Asai,
President, Alphatec Pacific -
Tom C Davis,
Director -
James R Glynn,
Director -
Rohit M Desai,
Director -
Luke T Faulstick,
Director -
William Patrick Ryan,
Chief Operating Officer -
Partners Ii L P Healthpoint...,
10% owner -
Ii, Llc Hgp,
10% owner -
Ross Simmonds,
Senior VP, Sales & Marketing -
Stephen Lubischer,
VP, Sales -
Reinecke Steven,
VP, Research & Development -
Richard Ravitch,
Director -
Oliver Burckhardt,
President, International -
Kermit P. Stott,
VP, Operations -
Co Invest Vehicle Ii, L.P. ...,
10% owner -
Peter C Wulff,
CFO, VP and Treasurer -
Dirk Kuyper,
President and CEO -
Brian Plotkin,
VP, Information Technology -
Jens Peter Timm,
VP, Research and Development -
Stephen Hochschuler,
Director -
Corp Chubb,
10% owner -
Partners Lp Healthpoint Cap...,
10% owner -
Llc Hgp,
10% owner -
Ii, Llchealthpointcapital P...,
-
Herbert J Bellucci,
VP, Manufacturing -
Stephen T D Dixon,
CFO, VP and Treasurer -
Vicky Romanoski,
Chief Admin Ofcr, VP & Scrty -
Insurance Co Federal,
10% owner -
Daniel Lacienski,
Executive VP, Operations -
Kimberly Bradshaw,
VP, Physician Services -
Steven Yasbek,
CFO, Treasurer and V.P. -
Shunshiro Yoshimi,
-
Ronald Hiscock,
President & CEO -
Scott Weise,
VP, Business Dev. & Marketing -
Trent Northcutt,
VP, Sales -
John Todd Koning,
CHIEF FINANCIAL OFFICER -
Marie Meynadier,
-
Elizabeth Ann Altman,
-
Paul Segal,
-
Tyson Eliot Marshall,
GENERAL COUNSEL & CORP. SEC. -
Andy Barnett,
Director -
Scott Lish,
CHIEF OPERATING OFFICER